Clinical Trial Update: TS Gene Polymorphism Predicts Effect in Patients With Advanced Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial results suggest that thymidylate synthase gene polymorphism may predict treatment effect in patients with advanced lung cancer (non-small cell lun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma
• Non-small Cell Lung Cancer

Snippet

Sponsor: Hunan Province Tumor Hospital | Conditions: Non-small-cell Lung Cancer, Adenocarcinoma | Phase 2 | Status: COMPLETED